NLRP3 activation is reported in AD and COVID-19, and is suggested by the formation of microglial nodules demonstrated in these cases (Lünemann et al., 2021; Herman and Pasinetti, 2018; Campbell et al., 2021). This evidence concerns the gene NLRP3 and Alzheimer disease.